Estrogen receptors in the diagnosis and treatment of hormone-dependent tumors
https://doi.org/10.14341/probl200955434-36
Abstract
The paper presents the current data available on the etiology of tumor diseases, among other things, shows the role of hormones, namely: estrogens and their receptors, in the mechanism responsible for the occurrence of these diseases. Each tumor was shown to have its receptor status and to be unresponsive to this or that therapy differently. The efficiency of treatment and its prognosis may be determined if the receptor composition of an involved organ is estimated correctly. The authors summarize the data available in the literature, as well as the results of their own investigations explaining the selective effect of estradiol receptor agonists and antagonists in various tissues. The mRNA varieties that potentially encoding for the synthesis of different subtypes of estrogen receptors (ER) - ER-α and ERβ, which are also coded by various genes located in different chromosomes. Pituitary adenomas as hormone-dependent masses are described in detail. The authors data on the concentration of nuclear estrogen receptors in different types of adenomas are given.
About the Authors
V N BabichevEndocrinology Research Centre
Russian Federation
E I Marova
Endocrinology Research Centre
Russian Federation
T A Fedotcheva
Endocrinology Research Centre
Russian Federation
N L Shimanovskiy
Russian State Medical University
Russian Federation
References
1. Бабичев В. Н., Марова Е. И., Кузнецова Т. А. и др. // Пробл. эндокринол. - 2007. - Т. 53, № 1. - С. 42-46.
2. Кадашев Б. А. Аденомы гипофиза. Клиника, диагностика, лечение. - М., 2007.
3. Федотчева Т. А., Шимановский Н. Л., Лапшина А. М., Бабичев В. Н. // XV Российский конгресс "Человек и лекарство": Тезисы докладов. - М., 2008. - С. 718.
4. Allegra J. C., Lippman V. E., Thompson E. B. et al. // Eur. J. Cancer. - 1980. - Vol. 16, N 3. - P. 323-331.
5. Asa S. L., Kelly M. L., Grandy D. K., Low M. // Endocrinology. - 1999. - Vol. 140. - P. 5348-5355.
6. Carolina Cristina, Graceila S. Diaz-Torda, Rodolfa G. Goya et al. // Mol. Cancer. - 2007. - Vol. 6, N 4. - P. 1-10.
7. Chaidarum S. S., Swearingen B., Alexander J. M. // J. Clin. Endocrinol. Metab. - 1998. - Vol. 83, N 9. - P. 3308-3315.
8. Childs G. V., Iruthayanathan M., Akter N., Johnson B. W. // Mol. Cell. Endocrinol. - 2006. - Vol. 9.247, N 1-2. - P. 60-63.
9. Garas A. // Clin. Endocrinol. (Oxford). - 2006. - Vol. 65, N 5. - P. 638-642.
10. Ginsburg E., Vonderhaar B. K. // Mol. Cell. Endocrinol. - 2007.
11. Gittoes N. J., McCabe C. J., Sheppard M. C., Franclyn J. A. // Pituitary. - 1999. - Vol. 1. - P. 99-104.
12. Hardin C., Pommier R., Calhoun K.et al. // Wld J. Surg. - 2007. - Vol. 31, N 5. - P. 1041-1046.
13. Heaney A. P., Fernando M., Melmed S. // J. Clin. Invest. - 2002. - Vol. 109. - P. 277-283.
14. Hopp T. A., Weiss H. L., Parra I. S. et al. // Clin. Cancer Res. - 2004. - Vol. 10, N 22. - P. 7490-7499.
15. Jensen E. V., Numata M., Blecher P. I. // Biochem. Soc. Symp. - 1971. - Vol. 32. - P. 133-159.
16. Kuiper G. G., Enmarki E., Pelto-Huikko M. et al. // Proc. Natl. Acad. Sci. USA. - 1996. - Vol. 93. - P. 5925-5930.
17. Matthews J., Gutafsson J. A. // Mol. Interv. - 2003. - Vol. 3, N 5. - P. 281-292.
18. Nahleh Z. // Future Oncol. - 2008. - Vol. 4, N 1. - P. 15-21.
19. Orrego J. J., Bair J. // Endocr. Pract. - 2006. - Vol. 12, N 2. - P. 174-178.
20. Roger P., Sahla M. E., Makela S. et al. // Cancer Res. - 2001. - Vol. 61, N 6. - P. 2537-2541.
21. Rugo H. S. // Ann. Oncol. - 2008. - Vol. 19, N 1. - P. 16-27.
22. Saji S., Hirose M., Toi M. // Cancer Chemother. Pharmacol. - 2005. - Vol. 56. - Suppl. 1. - P. 21-26.
23. Scott D. J., Parkes A. T., Ponchel F. et al. // Int. J. Oncol. - 2007. - Vol. 31, N 3. - P. 557-565.
24. Sengupta S., Jordan V. C. // Adv. Exp. Med. Biol. - 2008. - Vol. 630. - P. 206-219.
25. Xu R. K., Wu X. M., Di A. K. // Biol. Signals Recept. - 2000. - Vol. 9, N 1. - P. 1-20.
Review
For citations:
Babichev V.N., Marova E.I., Fedotcheva T.A., Shimanovskiy N.L. Estrogen receptors in the diagnosis and treatment of hormone-dependent tumors. Problems of Endocrinology. 2009;55(4):34-36. (In Russ.) https://doi.org/10.14341/probl200955434-36
Views:
6910
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
